NCT02753218View on ClinicalTrials.gov

A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Psoriasis Vulgaris

Interventions

DRUG

Midazolam

DRUG

LEO 32731

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd., Springfield House, Hyde Street, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY